Tuesday, April 2, 2019

Zydus Cadila gets tentative USFDA nod for overactive bladder treatment drug

Zydus Cadila gets tentative USFDA nod for overactive bladder treatment drug The company has received tentative approval from the United States Food and Drug Administration (USFDA) to market generic Mirabegron extended-release tablets in the strengths of 25 mg and 50 mg, Zydus Cadila said in a statement.

from Moneycontrol Business News https://ift.tt/2VbmuiT
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

US equities end lower as valuation concerns creep in

U.S. stocks closed lower on Wednesday as investors took profits amid concerns about high valuations flagged by Fed Chair Powell. The market ...